BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 38550581)

  • 1. Genetic and Epigenetic Regulation of the Innate Immune Response to Gout.
    de Lima JD; de Paula AGP; Yuasa BS; de Souza Smanioto CC; da Cruz Silva MC; Dos Santos PI; Prado KB; Winter Boldt AB; Braga TT
    Immunol Invest; 2023 Apr; 52(3):364-397. PubMed ID: 36745138
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic potential of procathepsin L-inhibiting and progesterone-entrapping dimethyl-β-cyclodextrin nanoparticles in treating experimental sepsis.
    Qiang X; Chen W; Zhu CS; Li J; Qi T; Lou L; Wang P; Tracey KJ; Wang H
    Front Immunol; 2024; 15():1368448. PubMed ID: 38550581
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytokine profiles as markers of disease severity in sepsis: a multiplex analysis.
    Bozza FA; Salluh JI; Japiassu AM; Soares M; Assis EF; Gomes RN; Bozza MT; Castro-Faria-Neto HC; Bozza PT
    Crit Care; 2007; 11(2):R49. PubMed ID: 17448250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated Circulating Procathepsin L as a Potential Biomarker of Inflamm-aging.
    Zhu CS; Chen W; Qiang X; Lou L; Li J; Wang H
    Med Hypotheses; 2024 May; 186():. PubMed ID: 38617026
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of Open Surface Plasmon Resonance (OpenSPR) to Characterize the Binding Affinity of Protein-Protein Interactions.
    Zhu CS; Li J; Wang H
    Bio Protoc; 2023 Sep; 13(17):e4795. PubMed ID: 37719081
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A two-decade journey in identifying high mobility group box 1 (HMGB1) and procathepsin L (pCTS-L) as potential therapeutic targets for sepsis.
    Li J; Zhu CS; He L; Qiang X; Chen W; Wang H
    Expert Opin Ther Targets; 2023; 27(7):575-591. PubMed ID: 37477229
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The multifunctional protein HMGB1: 50 years of discovery.
    Tang D; Kang R; Zeh HJ; Lotze MT
    Nat Rev Immunol; 2023 Dec; 23(12):824-841. PubMed ID: 37322174
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of Procathepsin L (pCTS-L)-Inhibiting Lanosterol-Carrying Liposome Nanoparticles to Treat Lethal Sepsis.
    Chen W; Zhu CS; Qiang X; Chen S; Li J; Wang P; Tracey KJ; Wang H
    Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37239992
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of procathepsin L (pCTS-L)-neutralizing monoclonal antibodies to treat potentially lethal sepsis.
    Zhu CS; Qiang X; Chen W; Li J; Lan X; Yang H; Gong J; Becker L; Wang P; Tracey KJ; Wang H
    Sci Adv; 2023 Feb; 9(5):eadf4313. PubMed ID: 36735789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lactate promotes endothelial-to-mesenchymal transition via Snail1 lactylation after myocardial infarction.
    Fan M; Yang K; Wang X; Chen L; Gill PS; Ha T; Liu L; Lewis NH; Williams DL; Li C
    Sci Adv; 2023 Feb; 9(5):eadc9465. PubMed ID: 36735787
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.